Syncom Formulations (India) Ltd
NSE:SYNCOMF
Syncom Formulations (India) Ltd
Intangible Assets
Syncom Formulations (India) Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Syncom Formulations (India) Ltd
NSE:SYNCOMF
|
Intangible Assets
₹472k
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Intangible Assets
₹100.9B
|
CAGR 3-Years
47%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Intangible Assets
₹19.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
26%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Intangible Assets
₹136.8B
|
CAGR 3-Years
32%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Intangible Assets
₹25.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Intangible Assets
₹40.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Syncom Formulations (India) Ltd
Glance View
Syncom Formulation India Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Indore, Madhya Pradesh. The firm manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquid orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments and inhalers. Its segments include Pharmaceuticals Drugs & Formulations, Trading of Commodities and Renting of property. Its product categories include tablets, capsules, ointments, injections, liquid-oral and packaging variants. The company offers various products, including generics, alpha adrenoceptor agonist, analgesic, antipyretic, anti-inflammatory, anti-ulcer agents, antibiotic, antidepressant, antiviral, cephelo sporins, cortico steroid, estrogen, cough suppressant and sedative anticonvulsant, among others. The firm operates in more than 15 countries across the world.
See Also
What is Syncom Formulations (India) Ltd's Intangible Assets?
Intangible Assets
472k
INR
Based on the financial report for Mar 31, 2025, Syncom Formulations (India) Ltd's Intangible Assets amounts to 472k INR.
What is Syncom Formulations (India) Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 3Y
-22%
Over the last year, the Intangible Assets growth was -57%. The average annual Intangible Assets growth rates for Syncom Formulations (India) Ltd have been -22% over the past three years .
